Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;89(2):423-425.
doi: 10.1016/j.jaad.2023.04.043. Epub 2023 Apr 29.

Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials

Riley K Spencer  1 , Joy Q Jin  2 , Kareem G Elhage  3 , Mitchell S Davis  3 , Marwa Hakimi  3 , Tina Bhutani  3 , Wilson Liao  4
Affiliations

Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials

Riley K Spencer et al. J Am Acad Dermatol. 2023 Aug.
No abstract available

Keywords: Otezla; acitretin; adalimumab; apremilast; bimekizumab; cyclosporine; etanercept; feet; guselkumab; hands; imsidolimab; infliximab; ixekizumab; methotrexate; network meta-analysis; palmoplantar; palms; psoriasis; pustulosis; secukinumab; soles; spesolimab; tofacitinib; upadacitinib; ustekinumab.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Dr Bhutani is a principal investigator for trials sponsored by AbbVie, Castle, CorEvitas, Dermavant, Galderma, Mindera, and Pfizer. She has served as an adviser for AbbVie, Arcutis, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, Pfizer, Sun, and UCB. Authors Spencer, Jin, and Elhage as well as Drs Davis, Hakimi, and Liao have no conflicts of interest to declare.

Publication types

MeSH terms